- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT03843190
Healthy Me: een programma voor oudere vrouwen
Veranderingen in gewicht en fysieke functie voor oudere Afro-Amerikaanse vrouwen in een nationaal, non-profit, community-based, peer-led, gewichtsverliesprogramma
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
North Carolina
-
Durham, North Carolina, Verenigde Staten, 27707
- Duke University
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Beschrijving
Inclusiecriteria:
- Afro-Amerikaanse vrouwen van ≥60 jaar
- BMI ≥30 kg/m2
- verminderde fysieke functie (d.w.z. degenen die scoren tussen 4 en 10 [van de 12] op de Short Physical Performance Battery [SPPB])
- Stabiel lichaamsgewicht (± 2 kg gedurende 6 maanden voorafgaand aan studie)
- Sedentair (niet meer dan 1 uur per week sporten)
Voorwaardelijke opnamecriteria:
Deelnemers met diabetes type 2 die insuline of sulfonylureumderivaten gebruiken, mogen alleen aan het onderzoek deelnemen als hun leveranciers ermee instemmen om de veranderende medicatievereisten in verband met mogelijk gewichtsverlies te beheren door een formulier "Toestemming om deel te nemen" te ondertekenen. Het is belangrijk om diabetes type 2 op insuline en sulfonylureumderivaten op te nemen, omdat deze deelnemers veel baat kunnen hebben bij gewichtsverlies.
Uitsluitingscriteria:
- Type 2-diabetici die insuline of sulfonylureumderivaten gebruiken zonder toestemming van de leverancier
- huidige kankerdiagnose
- gebruik van medicijnen waarvan wordt gedacht dat ze de stofwisseling, het lichaamsgewicht, het energieverbruik of de eetlust beïnvloeden
- ernstige psychiatrische stoornis
- huidige matige tot ernstige symptomen van depressie
- Dementie
- neurologische aandoeningen die functionele beperkingen veroorzaken
- onstabiele medische ziekte zoals onstabiele angina pectoris, recent MI of congestief hartfalen klasse III-IV
- terminale medische aandoeningen
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Op een verantwoorde manier kilo's kwijtraken (TOPS)
Deze groep krijgt bij aanvang van het onderzoek TOPS-interventie.
|
Dietitian-facilitated classes
|
|
Ander: Wachtlijst controle
Deze groep zal gedurende 6 maanden de controlegroep zijn.
Na voltooiing van de studie ontvangen ze de vouchers om deel te nemen aan TOPS-afdelingen in de gemeenschap.
|
Aan het einde van de studie werden peer-geleide lessen aangeboden om bij te wonen.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Weight Change
Tijdsspanne: Baseline to 6 months
|
Percent of body weight change over 6 months
|
Baseline to 6 months
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Systolic Blood Pressure (BP)
Tijdsspanne: Baseline, 3 months, 6 months
|
A measure of cardiovascular disease (CVD) risk.
|
Baseline, 3 months, 6 months
|
|
Diastolic Blood Pressure (BP)
Tijdsspanne: Baseline, 3 months, 6 months
|
A measure of cardiovascular disease (CVD) risk.
|
Baseline, 3 months, 6 months
|
|
Waist Circumference (WC)
Tijdsspanne: Baseline, 3 months, 6 months
|
A measure of cardiovascular disease (CVD) risk.
|
Baseline, 3 months, 6 months
|
|
Hemoglobin A1c (HA1c)
Tijdsspanne: Baseline, 3 months, 6 months
|
Percentage of hemoglobin that is coated with glucose.
A measure of cardiovascular disease (CVD) risk.
|
Baseline, 3 months, 6 months
|
|
HDL (High-Density Lipoprotein) Cholesterol
Tijdsspanne: Baseline, 3 months, 6 months
|
A measure of cardiovascular disease (CVD) risk.
|
Baseline, 3 months, 6 months
|
|
LDL (Low-Density Lipoprotein) Cholesterol, Calculated
Tijdsspanne: Baseline, 3 months, 6 months
|
A measure of cardiovascular disease (CVD) risk.
|
Baseline, 3 months, 6 months
|
|
LDL (Low-Density Lipoprotein) Cholesterol, Direct
Tijdsspanne: Baseline, 3 months, 6 months
|
A measure of cardiovascular disease (CVD) risk.
|
Baseline, 3 months, 6 months
|
|
Triglycerides
Tijdsspanne: Baseline, 3 months, 6 months
|
A measure of cardiovascular disease (CVD) risk.
|
Baseline, 3 months, 6 months
|
|
Quality of Life (QoL) as Measured by 36-item Short Form Survey (SF-36) - General Health
Tijdsspanne: Baseline, 3 months, 6 months
|
The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section.
Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight.
The lower the score the more disability.
The higher the score the less disability, i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.
|
Baseline, 3 months, 6 months
|
|
Quality of Life (QoL) as Measured by 36-item Short Form Survey (SF-36) - Physical Functioning
Tijdsspanne: Baseline, 3 months, 6 months
|
The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section.
Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight.
The lower the score the more disability.
The higher the score the less disability, i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.
|
Baseline, 3 months, 6 months
|
|
Quality of Life (QoL) as Measured by 36-item Short Form Survey (SF-36) - Role Functioning/Physical
Tijdsspanne: Baseline, 3 months, 6 months
|
The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section.
Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight.
The lower the score the more disability.
The higher the score the less disability, i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.
|
Baseline, 3 months, 6 months
|
|
Quality of Life (QoL) as Measured by 36-item Short Form Survey (SF-36) - Role Functioning/Emotional
Tijdsspanne: Baseline, 3 months, 6 months
|
The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section.
Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight.
The lower the score the more disability.
The higher the score the less disability, i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.
|
Baseline, 3 months, 6 months
|
|
Quality of Life (QoL) as Measured by 36-item Short Form Survey (SF-36) - Energy/Fatigue
Tijdsspanne: Baseline, 3 months, 6 months
|
The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section.
Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight.
The lower the score the more disability.
The higher the score the less disability, i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.
|
Baseline, 3 months, 6 months
|
|
Quality of Life (QoL) as Measured by 36-item Short Form Survey (SF-36) - Emotional Well-being
Tijdsspanne: Baseline, 3 months, 6 months
|
The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section.
Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight.
The lower the score the more disability.
The higher the score the less disability, i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.
|
Baseline, 3 months, 6 months
|
|
Quality of Life (QoL) as Measured by 36-item Short Form Survey (SF-36) - Social Functioning
Tijdsspanne: Baseline, 3 months, 6 months
|
The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section.
Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight.
The lower the score the more disability.
The higher the score the less disability, i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.
|
Baseline, 3 months, 6 months
|
|
Quality of Life (QoL) as Measured by 36-item Short Form Survey (SF-36) - Pain
Tijdsspanne: Baseline, 3 months, 6 months
|
The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section.
Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight.
The lower the score the more disability.
The higher the score the less disability, i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.
|
Baseline, 3 months, 6 months
|
|
Healthcare Utilization as Measured by Number of Primary Care Visits
Tijdsspanne: Baseline, 3 months, 6 months
|
Number of primary care visits reported by participant in last month (baseline) or since last study visit (3 and 6 months).
|
Baseline, 3 months, 6 months
|
|
Healthcare Utilization as Measured by Number of Participants With Emergency Department Visits
Tijdsspanne: Baseline, 3 months, 6 months
|
Number of participants reporting emergency department visit(s) in last month (baseline) or since last study visit (3 and 6 months).
|
Baseline, 3 months, 6 months
|
|
Healthcare Utilization as Measured by Number of Participants With Hospitalizations
Tijdsspanne: Baseline, 3 months, 6 months
|
Number of participants reporting hospitalization(s) in last month (baseline) or since last study visit (3 and 6 months).
|
Baseline, 3 months, 6 months
|
|
Physical Function as Measured by Short Physical Performance Battery (SPPB)
Tijdsspanne: Baseline, 3 months, 6 months
|
The Short Physical Performance Battery (SPPB) is an objective measurement instrument of balance, lower extremity strength, and functional capacity in older adults.
Scores range from zero to 12 possible points.
Lower scores are associated with lower function.
|
Baseline, 3 months, 6 months
|
|
Physical Function as Measured by 8-ft Up and Go
Tijdsspanne: Baseline, 3 months, 6 months
|
The 8-foot up-and-go test is a timed test that measures balance, agility, and speed while walking or moving.
Higher times are associated with worse physical function.
|
Baseline, 3 months, 6 months
|
|
Physical Function as Measured by Isometric Hand Grip, Right Hand
Tijdsspanne: Baseline, 3 months, 6 months
|
Decreased grip strength is a predictor of adverse outcomes in older adults.
|
Baseline, 3 months, 6 months
|
|
Physical Function as Measured by Isometric Hand Grip, Left Hand
Tijdsspanne: Baseline, 3 months, 6 months
|
Decreased grip strength is a predictor of adverse outcomes in older adults.
|
Baseline, 3 months, 6 months
|
|
Physical Function as Measured by 30 Second Chair Stands
Tijdsspanne: Baseline, 3 months, 6 months
|
Counts the number of times a participant goes from sitting to standing in 30 seconds.
Tests leg strength and endurance.
Higher number associated with higher leg strength and endurance.
|
Baseline, 3 months, 6 months
|
|
Physical Function as Measured by 6 Minute Walk Test
Tijdsspanne: Baseline, 3 months, 6 months
|
Measures distance walked in 6 minutes and assesses aerobic capacity and endurance.
Higher number indicates higher aerobic capacity and endurance.
|
Baseline, 3 months, 6 months
|
Medewerkers en onderzoekers
Sponsor
Medewerkers
Onderzoekers
- Hoofdonderzoeker: Nia S Mitchell, MD, MPH, Duke University
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- Pro00100588
- R01AG058725 (Subsidie/contract van de Amerikaanse NIH)
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .